guest ::
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia : final results from the BFORE trial
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
In
Leukemia : normal and malignant hemopoiesis 36(7), Seiten/Artikel-Nr.:1825-1833
2022
Online
DOI: 10.1038/s41375-022-01589-y
DOI: 10.18154/RWTH-2022-06825
URL: https://publications.rwth-aachen.de/record/849469/files/849469.pdf
Einrichtungen
Projekte
Thematische Einordnung (Klassifikation)
DDC: 610
OpenAccess: 
PDF
Dokumenttyp
Journal Article
Format
online, print
Sprache
English
Anmerkung
Peer reviewed article
Externe Identnummern
WOS Core Collection: WOS:000803301800001
PubMed: pmid:35643868
SCOPUS: SCOPUS:2-s2.0-85133871622
Interne Identnummern
RWTH-2022-06825
Datensatz-ID: 849469
Beteiligte Länder
Canada, France, Germany, Italy, Mexico, Singapore, Spain, UK, USA
; 
; 
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
PDF